Myezom 2mg Injection

About Myezom 2mg Injection

Myezom 2mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma. It shows its working by stopping or slowing down the growth of cancer cells.Myezom 2mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.Fatigue, nausea, vomiting, and loss of appetite are some common side effects of this medicine. You may be advised to drink plenty of fluids every day during the treatment. You should not drive or operate machinery as medicine may cause tiredness and dizziness. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.Before taking Myezom 2mg Injection, consult with your doctor if you have any liver, kidney, heart disease or bleeding problem. It is important to consult a doctor if you develop symptoms like memory loss or trouble in thinking. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Advanced Treatment for Hematologic Cancers

Myezom 2mg Injection offers a proven treatment option for adults with multiple myeloma and mantle cell lymphoma. Its active ingredient, Bortezomib, interferes with cancer cell survival, providing significant clinical benefits. The formulation is delivered as a lyophilized powder, ensuring stable and precise dosing when reconstituted by healthcare professionals.


Safe Administration-Hospital Use Only

To ensure optimal safety and efficacy, Myezom is indicated strictly for hospital use and must not be self-administered. Administration routes include intravenous or subcutaneous injection, determined by the healthcare provider according to specific patient needs.


Quality Assurance and Storage

Each glass vial is produced under stringent conditions in India, ensuring pharmaceutical quality. For best results, store Myezom below 25C, away from light, and adhere to the shelf life of 24 months from the manufacturing date. Proper handling preserves its potency during cancer therapy.